Recall Atlas

Mylan Institutional recalls

3 official recalls and safety alerts involving Mylan Institutional since 2022-05, from FDA · Drug. Newest first. Check the official notice for exact models and batch codes.

This list only includes recalls Recall Atlas has collected since 2021-10. A product not listed here may still be affected; check with Mylan Institutional or the relevant agency.

  1. 2025-03-26
  2. US
    Drugs & medicalClass II

    Mylan Institutional, Inc. recalls Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), Rx Only, 100 Unit Dose Blister Cards of 10 (10 cards of 10 tablets each) per…

    Super-Potent Drug: Out of specification potency results were obtained.

    FDA · DrugMylan Institutional, Inc.Nationwide in the USAOfficial notice →
  3. 2024-12-18
  4. US
    Drugs & medicalClass II

    Mylan Institutional, Inc. recalls Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 100 Tablets per carton (10 unit dose blister cards of 10 tablets each), Rx only,…

    Subpotent and Superpotent Drug

    FDA · DrugMylan Institutional, Inc.Nationwide in the USA.Official notice →
  5. 2022-05-18
  6. US
    Drugs & medicalClass II

    Mylan Institutional, Inc. (d.b.a. UDL Laboratories) recalls Esomeprazole Magnesium Delayed-Release Capsules, USP 20 mg, packaged in Unit Dose Blister Cards of 6 (10…

    Failed Impurities/Degradation Specifications: OOS result was obtained for Any Other Individual Impurity at the 12M room temperature time point.

    FDA · DrugMylan Institutional, Inc. (d.b.a. UDL Laboratories)Nationwide within USAOfficial notice →